• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Postoperative radiotherapy for malignant tumors of the parotid gland.

作者信息

Garden A S, el-Naggar A K, Morrison W H, Callender D L, Ang K K, Peters L J

机构信息

Department of Radiotherapy, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):79-85. doi: 10.1016/s0360-3016(96)00464-6.

DOI:10.1016/s0360-3016(96)00464-6
PMID:9054880
Abstract

PURPOSE

To update our experience using postoperative irradiation in selected patients with carcinomas of the parotid gland. Outcomes of treatment with a focus on the effectiveness of the two primary techniques of radiation used for treating these tumors were evaluated.

METHODS AND MATERIALS

A retrospective analysis of 166 patients with parotid gland malignancies treated in the Department of Radiotherapy at the University of Texas M. D. Anderson Cancer Center between 1965-1989 was performed. All patients were treated following surgery and did not have macroscopic disease at the time of their radiation. The most common histologies were mucoepidermoid carcinoma (28%) and adenocarcinoma (27%). Pathologic features constituting indications for postoperative radiotherapy included: inadequate margins, 104 (63%) cases; extraglandular disease extension, 82 (49%); perineural invasion 57 (34%); and nodal disease 43 (26%). Radiation was delivered through an ipsilateral field of predominantly high energy electrons in 142 patients (86%). Wedged paired 60Co fields were used to treat 19 patients. The median dose was 60 Gy, typically delivered at 2 Gy per fraction. The median follow-up time for surviving patients was 155 months.

RESULTS

Forty-seven (29%) patients had disease recurrence, of whom 15 (9%) had disease recur locally and 10 (6%) regionally (neck). There was no association between the dose of radiation and local failure, except for a trend for patients with positive margins and/or named nerve involvement to have improved local control if they received doses > 60 Gy. There was no difference in failure rates in patients treated with wedged pair techniques or ipsilateral fields, but there was a higher complication rate in the former. Overall, 37 patients (22%) developed chronic sequelae attributed to radiation. Twelve patients developed decreased hearing, and 15 patients developed soft tissue or bone necrosis or exposure.

CONCLUSIONS

Local and regional control rates for high risk patients with parotid gland carcinomas treated with radiation following surgery were excellent. The technique of using an ipsilateral field encompassing the parotid bed and treated with high energy electrons often mixed with photons was effective with minimal severe late toxicity. The moderate complication rate experienced in this series can be further reduced using modern techniques as described.

摘要

相似文献

1
Postoperative radiotherapy for malignant tumors of the parotid gland.
Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):79-85. doi: 10.1016/s0360-3016(96)00464-6.
2
Long-term outcomes and quality of life of 186 patients with primary parotid carcinoma treated with surgery and radiotherapy at the Daniel den Hoed Cancer Center.丹尼尔·丹霍德癌症中心 186 例原发性腮腺癌患者手术联合放疗的长期疗效及生活质量。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):189-95. doi: 10.1016/j.ijrobp.2011.11.045. Epub 2012 Feb 11.
3
Prognostic Factors and Clinical Outcome in Parotid Gland Tumors: a Single Institution Experience from the Eastern Black Sea Region of Turkey.腮腺肿瘤的预后因素及临床结局:来自土耳其黑海东部地区一家机构的经验
Asian Pac J Cancer Prev. 2016;17(3):1169-74. doi: 10.7314/apjcp.2016.17.3.1169.
4
Three-dimensional conformal postoperative radiotherapy in patients with parotid tumors: 10 years' experience at the European Institute of Oncology.腮腺肿瘤患者的三维适形术后放疗:欧洲肿瘤研究所10年经验
Tumori. 2011 May-Jun;97(3):328-34. doi: 10.1177/030089161109700312.
5
Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005.根治性放射治疗恶性腮腺肿瘤:单中心1995 - 2005年经验
Br J Oral Maxillofac Surg. 2009 Jun;47(4):284-9. doi: 10.1016/j.bjoms.2008.12.012. Epub 2009 Feb 4.
6
The influence of positive margins and nerve invasion in adenoid cystic carcinoma of the head and neck treated with surgery and radiation.手术联合放疗治疗头颈部腺样囊性癌时切缘阳性及神经侵犯的影响
Int J Radiat Oncol Biol Phys. 1995 Jun 15;32(3):619-26. doi: 10.1016/0360-3016(95)00122-F.
7
Definitive carbon-ion radiotherapy for locally advanced parotid gland carcinomas.局部晚期腮腺癌的确定性碳离子放射治疗
Head Neck. 2017 Apr;39(4):724-729. doi: 10.1002/hed.24671. Epub 2016 Dec 22.
8
Intraoperative radiotherapy for parotid cancer: a single-institution experience.腮腺癌术中放疗:单中心经验。
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1831-6. doi: 10.1016/j.ijrobp.2011.02.033. Epub 2011 Apr 20.
9
High-grade malignancies of the parotid gland: effective use of planned combined surgery and irradiation.腮腺高级别恶性肿瘤:计划性联合手术与放疗的有效应用。
Laryngoscope. 1985 Sep;95(9 Pt 1):1059-63.
10
Postoperative radiation therapy for malignant tumors of minor salivary glands. Outcome and patterns of failure.小唾液腺恶性肿瘤的术后放射治疗。结果及失败模式。
Cancer. 1994 May 15;73(10):2563-9. doi: 10.1002/1097-0142(19940515)73:10<2563::aid-cncr2820731018>3.0.co;2-x.

引用本文的文献

1
Response efficacy of PD-1 and PD-L1 inhibitors in salivary gland cancers: a systematic review and meta-analysis.PD-1和PD-L1抑制剂在唾液腺癌中的反应疗效:一项系统评价和荟萃分析。
Front Oncol. 2025 Apr 2;15:1534343. doi: 10.3389/fonc.2025.1534343. eCollection 2025.
2
Surgical Approaches to Pre-Auricular Cutaneous Squamous Cell Carcinomas Extending to the Temporal Bone.针对累及颞骨的耳前皮肤鳞状细胞癌的手术入路
Head Neck. 2025 Jun;47(6):1736-1748. doi: 10.1002/hed.28073. Epub 2025 Jan 25.
3
Dosimetric and NTCP analyses for selecting parotid gland cancer patients for proton therapy.
用于选择腮腺癌患者进行质子治疗的剂量学和正常组织并发症概率分析。
Tumori. 2024 Aug;110(4):273-283. doi: 10.1177/03008916241252544. Epub 2024 May 21.
4
Incidence and Possible Predictive Factors of Facial Nerve Paralysis after Superficial Parotidectomy for Benign Tumours: Our Experience.腮腺浅叶良性肿瘤切除术后面神经麻痹的发生率及可能的预测因素:我们的经验
Indian J Otolaryngol Head Neck Surg. 2023 Sep;75(3):2000-2005. doi: 10.1007/s12070-023-03690-9. Epub 2023 Apr 24.
5
Pembrolizumab as a first line therapy in a patient with extensive mucoepidermoid salivary gland carcinoma. A complete clinical, radiological and pathological response. A very specific case.帕博利珠单抗作为广泛型黏液表皮样唾液腺癌患者的一线治疗。完全的临床、影像学和病理反应。一个非常特殊的病例。
Discov Oncol. 2022 May 28;13(1):37. doi: 10.1007/s12672-022-00502-4.
6
Adjuvant radiotherapy in malignant tumors of parotid. Experience of the Navarra Hospital Complex.腮腺恶性肿瘤的辅助放疗。纳瓦拉医院联合体的经验。
Rep Pract Oncol Radiother. 2021 Dec 30;26(6):962-967. doi: 10.5603/RPOR.a2021.0118. eCollection 2021.
7
A study of 24 cases of salivary gland carcinoma with distant metastasis.一项针对24例伴有远处转移的唾液腺癌的研究。
Mol Clin Oncol. 2021 Sep;15(3):183. doi: 10.3892/mco.2021.2345. Epub 2021 Jul 3.
8
Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.基于人群分析的预测腮腺癌特定原因死亡率的竞争风险列线图。
Cancer Med. 2021 Jun;10(11):3756-3769. doi: 10.1002/cam4.3919. Epub 2021 May 7.
9
The Role of Postoperative Radiotherapy and Prognostic Model in Primary Squamous Cell Carcinoma of Parotid Gland.术后放疗及预后模型在腮腺原发性鳞状细胞癌中的作用
Front Oncol. 2021 Feb 15;10:618564. doi: 10.3389/fonc.2020.618564. eCollection 2020.
10
Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy.采用质子束放射疗法治疗主要涎腺肿瘤的结果和预后因素。
Head Neck. 2021 Apr;43(4):1056-1062. doi: 10.1002/hed.26563. Epub 2021 Feb 19.